首页> 美国卫生研究院文献>other >Type 2 Diabetes Biomarkers of Human Gut Microbiota Selected via Iterative Sure Independent Screening Method
【2h】

Type 2 Diabetes Biomarkers of Human Gut Microbiota Selected via Iterative Sure Independent Screening Method

机译:通过迭代确定性独立筛选方法选择人类肠道菌群的2型糖尿病生物标志物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Type 2 diabetes, which is a complex metabolic disease influenced by genetic and environment, has become a worldwide problem. Previous published results focused on genetic components through genome-wide association studies that just interpret this disease to some extent. Recently, two research groups published metagenome-wide association studies (MGWAS) result that found meta-biomarkers related with type 2 diabetes. However, One key problem of analyzing genomic data is that how to deal with the ultra-high dimensionality of features. From a statistical viewpoint it is challenging to filter true factors in high dimensional data. Various methods and techniques have been proposed on this issue, which can only achieve limited prediction performance and poor interpretability. New statistical procedure with higher performance and clear interpretability is appealing in analyzing high dimensional data. To address this problem, we apply an excellent statistical variable selection procedure called iterative sure independence screening to gene profiles that obtained from metagenome sequencing, and 48/24 meta-markers were selected in Chinese/European cohorts as predictors with 0.97/0.99 accuracy in AUC (area under the curve), which showed a better performance than other model selection methods, respectively. These results demonstrate the power and utility of data mining technologies within the large-scale and ultra-high dimensional genomic-related dataset for diagnostic and predictive markers identifying.
机译:2型糖尿病是一种受基因和环境影响的复杂代谢疾病,已成为世界性难题。先前发表的结果通过全基因组关联研究集中在遗传成分上,这些研究只是在某种程度上解释了这种疾病。最近,两个研究小组发表了全基因组关联研究(MGWAS)结果,发现了与2型糖尿病相关的元生物标志物。但是,分析基因组数据的一个关键问题是如何处理特征的超高维。从统计角度来看,在高维数据中过滤真实因素具有挑战性。已经针对此问题提出了各种方法和技术,这些方法和技术只能实现有限的预测性能和较差的可解释性。具有较高性能和清晰可解释性的新统计程序在分析高维数据方面具有吸引力。为了解决这个问题,我们对元基因组测序获得的基因谱应用了一种出色的统计变量选择程序,称为迭代确定独立性筛选,并在中国/欧洲人群中选择了48/24个元标记作为AUC预测值为0.97 / 0.99的预测因子(曲线下的面积),分别显示出比其他模型选择方法更好的性能。这些结果证明了在大规模和超高维基因组相关数据集中用于诊断和预测标记识别的数据挖掘技术的功能和实用性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号